AGY.L
Allergy Therapeutics PLC
Price:  
6.30 
GBP
Volume:  
1,514,406.00
United Kingdom | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AGY.L WACC - Weighted Average Cost of Capital

The WACC of Allergy Therapeutics PLC (AGY.L) is 7.3%.

The Cost of Equity of Allergy Therapeutics PLC (AGY.L) is 7.15%.
The Cost of Debt of Allergy Therapeutics PLC (AGY.L) is 10.05%.

Range Selected
Cost of equity 6.00% - 8.30% 7.15%
Tax rate 11.10% - 15.20% 13.15%
Cost of debt 7.00% - 13.10% 10.05%
WACC 6.0% - 8.6% 7.3%
WACC

AGY.L WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 6.0% 7.0%
Adjusted beta 0.34 0.47
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.00% 8.30%
Tax rate 11.10% 15.20%
Debt/Equity ratio 0.13 0.13
Cost of debt 7.00% 13.10%
After-tax WACC 6.0% 8.6%
Selected WACC 7.3%